Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.

Li S, Gao Y, Ma W, Cheng T, Liu Y

DOI: 10.1007/s13277-015-3759-6
Published: 2016 Dec
Container: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13277-015-3759-6,
  title = {Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.},
  author = {Li S and Gao Y and Ma W and Cheng T and Liu Y},
  year = {2016},
  journal = {Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine},
  doi = {10.1007/s13277-015-3759-6},
  url = {https://doi.org/10.1007/s13277-015-3759-6}
}

RIS

TY  - JOUR
TI  - Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.
AU  - Li S
AU  - Gao Y
AU  - Ma W
AU  - Cheng T
AU  - Liu Y
PY  - 2016
JO  - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
DO  - 10.1007/s13277-015-3759-6
UR  - https://doi.org/10.1007/s13277-015-3759-6
ER  -

APA

S, L., Y, G., W, M., T, C., & Y, L. (2016). Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. https://doi.org/10.1007/s13277-015-3759-6

Source records

pubmed · retrieved 2026-09-26T02:22:38.857Z
europe-pmc · retrieved 2026-09-26T02:22:38.876Z